Edition:
United States

HBM Healthcare Investments AG (HBMN.S)

HBMN.S on Swiss Exchange

168.20CHF
11:30am EDT
Change (% chg)

CHF1.20 (+0.72%)
Prev Close
CHF167.00
Open
CHF167.40
Day's High
CHF168.40
Day's Low
CHF167.40
Volume
11,893
Avg. Vol
9,092
52-wk High
CHF169.60
52-wk Low
CHF110.50

Chart for

About

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer... (more)

Overall

Beta: 0.55
Market Cap(Mil.): CHF1,175.68
Shares Outstanding(Mil.): 7.04
Dividend: 5.50
Yield (%): 4.19

Financials

  HBMN.S Industry Sector
P/E (TTM): 10.04 28.43 19.89
EPS (TTM): 16.64 -- --
ROI: 9.45 6.81 0.57
ROE: 10.28 13.59 16.40

BRIEF-HBM Healthcare Investments FY Net Profit Of Around CHF 115 Million

* SAID ON TUESDAY EXPECTED FY NET PROFIT OF AROUND CHF 115 MILLION

Apr 04 2018

BRIEF-HBM Healthcare Investments 9-Mth Profit At CHF 85.6 Mln

* PROFIT FOR THE FIRST NINE MONTHS OF THE 2017/2018 FINANCIAL YEAR AT A TOTAL OF CHF 85.6 MILLION

Jan 25 2018

BRIEF-HBM Healthcare Investments Expects Profit Of Over CHF 85 Million For First 9 Months Of 2017/2018‍​

* FOR FIRST NINE MONTHS OF 2017/2018, EXPECTS A PROFIT OF OVER CHF 85 MILLION‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jan 03 2018

BRIEF-CSL And HBM Portfolio Company Vitaeris Announce Strategic Partnership

* CSL AND HBM PORTFOLIO COMPANY VITAERIS ANNOUNCE STRATEGIC PARTNERSHIP WITH OPTION TO ACQUIRE Source text - http://bit.ly/2jhdF6b Further company coverage: (Gdynia Newsroom)

Dec 05 2017

Earnings vs. Estimates